Table 1.
Donor no. | Sex | Age, years | Lung lobe | Weight, length × width × height | Diagnostic finding | Smoker status | Methods and analysis | Processing | Chemotherapy or radiotherapy |
---|---|---|---|---|---|---|---|---|---|
1 | Male | 71 | LL, right | 29 g, 13 × 4.5 × 2 cm | Filiae of a non–small cell carcinoma with low differentiation after bladder cancer | No smoking | WST-1 and LDH assay, cilia check, histologic evaluation, RNA sequencing | Immediate | No |
2 | Male | 55 | UL, left | 7 × 3 × 3.5 cm | NSCLC after anaplastic thyroid cancer | 60 py until 6 years before surgery | WST-1 and LDH assay, cilia check, histologic evaluation | Immediate | Radioiodo-therapy |
3 | Female | 71 | UL, left | 155 g, 15 × 10 × 3 cm | Squamous cell carcinoma with low cornification and low differentiation | 20 py until 6 years before surgery | WST-1 and LDH assays, cilia check, histologic evaluation | Immediately filled, then stored overnight at 4°C, before further processed | No |
4 | Female | 75 | LL, left | 30 g, 10 × 6 × 3 cm | Adenocarcinoma | Until 16 years before surgery | WST-1 and LDH assays, cilia check, histologic evaluation | Immediate | No |
5 | Female | 76 | UL, left | 18 × 12 × 6 cm | NSCLC, adenocarcinoma | No smoking | WST-1 and LDH assays, cilia check, histologic evaluation | Immediately filled, then stored overnight at 4°C, before further processed | No |
6 | Male | 69 | UL, right | 131 g, 14 × 8.5 × 3 cm | Adenocarcinoma | 75 py | WST-1 and LDH assays, cilia check, histologic evaluation | Immediate | No |
7 | Male | 68 | UL, left | 589 g, 24 × 15 × 7 cm | NSCLC, adenocarcinoma with low differentiation | No smoking | WST-1 and LDH assays, cilia check, histologic evaluation, RNA sequencing | Immediate | No |
8 | Male | 57 | LL, left | 493 g, 18 × 13.5 × 4.6 cm | Invasive adenocarcinoma | 20 py | WST-1 and LDH assays, cilia check, histologic evaluation, RNA sequencing | Immediate | No |
9 | Male | 58 | UL, right | 300 g, 19 × 15 × 3.5 cm | Squamous cell carcinoma with cornification | 110 py | WST-1 and LDH assays, cilia check, histologic evaluation | Immediate | No |
10 | Female | 62 | LL, ML, right | 565 g, 22 × 12 × 4.5 cm | Fibrosis, sarcoidosis | 15 py until 19 years before surgery | Histologic evaluation | Immediately filled, then stored overnight at 4°C, before further processed | |
11 | Female | 55 | UL, LL, right | 498 g, 19.5 × 12 × 6 cm | Fibrosis, UIP pattern, IPF | No smoking | WST-1 and LDH assays, cilia check, histologic evaluation | Tissue stored overnight at 4°C, then processed | |
12 | Female | 50 | UL, LL, right | 432 g, 21 × 13.5 × 4 cm | Fibrosis, UIP-pattern, antisynthetase Syndrome | 20 py until 3 years before surgery | WST-1 and LDH assay, cilia check, histologic evaluation | Tissue stored overnight at 4°C, then processed | |
13 | Male | 59 | UL, LL, right | 585 g, 22 × 18 × 7 cm | Fibrosis, clinical NSIP | 2 py until 37 years before surgery | WST-1 and LDH assay, cilia checks, histologic evaluation | Tissue stored overnight at 4°C, then processed | |
14 | Male | 62 | UL, right | 556 g, 18.5 × 14 × 3.5 cm | Fibrosis, chronic interstitial pneumonia, UIP pattern | 22 py until 22 years before surgery | WST-1 and LDH assays, cilia check, histologic evaluation | Immediate | |
15 | Male | 34 | UL, LL, right | 582 g, 22.5 × 14.5 × 5 cm | Fibrosis, IPF | No smoking | WST-1 and LDH assays, cilia check, histologic evaluation | Immediate | |
16 | Female | 50 | UL, ML, right | 389 g, 20 × 12.5 × 3 cm | Fibrosis, UIP pattern, ANCA-positive interstitial pneumonia | No smoking | WST-1 and LDH assays, cilia check, histologic evaluation | Immediate |
ANCA, antineutrophil cytoplasm autoantibodies; IPF, idiopathic pulmonary fibrosis; LDH, lactate dehydrogenase; LL, lower lobe; ML, middle lobe; NSCLC, non–small cell lung cancer; NSIP, nonspecific interstitial pneumonia; py, pack-years; UIP, usual interstitial pneumonia; UL, upper lobe; WST-1, water soluble tetrazolium 1.